Browse by Medical Category
Not Accepting New Patients
Andrew Warshaw, MD, is Surgeon-in-Chief, Emeritus, at MGH and W. Gerald Austen Professor of Surgery at Harvard Medical School. He is Senior Consultant in International and Regional Clinical Relations at MGH and Partners Healthcare.
Go To Programs
Go To Specialties
Digestive Healthcare Center
Go To Specialties
Andrew Warshaw, MD, FACS is a graduate of Harvard College and Harvard Medical School and trained in surgery at Massachusetts General Hospital. He also spent two years as a clinical associate in the Section on Gastroenterology of the National Institutes of Health and was a research fellow in medicine at Massachusetts General Hospital. Since 1972, he has been on the staff at Massachusetts General Hospital and on the faculty of Harvard Medical School. In 1987, he became professor of surgery at Harvard and in 1997, the W. Gerald Austen Professor of Surgery, surgeon-in-chief and chairman of the department of surgery at Massachusetts General Hospital.
Dr. Warshaw has been president of the Society for Surgery of the Alimentary Tract, the International Association of Pancreatology, the Massachusetts Chapter of the American College of Surgeons (ACS), the New England Surgical Society, the Halsted Society, the Boston Surgical Society, the Society of Surgical Chairs, and the American Pancreatic Association. He was a director of the American Board of Surgery and its chairman in 1993. He has served as a governor of the ACS and chair of its Socioeconomic Issues Committee. He has been first vice president of the ACS, a member of its Health Policy Steering Committee, and chair of the board of directors of the ACS Professional Association/Political Action Committee. In 2007, he was appointed treasurer of the ACS. He also chairs the ACS Health Policy and Advocacy Group.
Dr. Warshaw has made important contributions to the diagnosis, treatment and understanding of the pathogenesis of inflammatory and malignant lesions of the pancreas. His bibliography lists nearly 400 original reports as well as 240 book chapters, reviews, and monographs and 13 books. He is editor-in-chief of the journal SURGERY.
In 1972, Warshaw founded the world-renowned Massachusetts General Hospital Pancreatic Biology Laboratory, which has contributed significantly to the understanding of the pathogenesis of severe acute pancreatitis and its treatment and to the study of the molecular biology and genetics of pancreatic cancer and other pancreatic tumors.
He has developed new operations for pancreatic diseases, improved the preoperative evaluation of pancreatic cancers with the combined use of CT, laparoscopy and cytology, and is a pioneer in the field of pancreatic cystic tumors. His group has one of the largest U.S. experiences in management of pancreatic tumors and leads the field in safe outcomes.
Among Warshaws awards are: Honorary Fellowship, Society of Black Academic Surgeons (2005); Boston Medical Journal Lifetime Achievement Award (2004); Founders Medal, Society for Surgery of the Alimentary Tract (2003); and James Ewing Medal, Society of Surgical Oncology (2002).
Warshaw is Director of the Warshaw Institute for Pancreatic Cancer Research at the Massachusetts General Hospital.
View my most recent publications at PubMed
Hutter MM, Kellogg KC, Ferguson CM, Abbott WM, Warshaw AL. The impact of the 80-hour work week on surgical residents and attending surgeons. Ann Surg 2006;243:864-871.
Hutter MM, Randall S, Khuri SF, Henderson WG, Abbot WM, Warshaw AL. Laparoscopic versus open gastric bypass for morbid obesity: a multicenter, prospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Ann Surg 2006;243:657-662.
Crippa S, Dominguez I, Rodriguez JR, Razo O, Thayer SP, Ryan DP, Warshaw AL, Fernandez-del Castillo C. Quality of life in pancreatic cancer: Analysis by stage and treatment. J Gastrointest Surg 2008;12:783-794.
Rodriguez JR, Razo AL, Targarona J, Thayer SP, Rattner DW, Warshaw AL, Fernandez-del Castillo C. Debridement and closed packing for sterile or infected necrotizing pancreatitis: Insights into indications and outcomes in 167 patients. Ann Surg 2008;247:294-299.
Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR, Fernandez-del Castillo C. Improved contemporary surgical management of insulinomas: A 25-year experience at the Massachusetts General Hospital. Ann Surg 2008;247:165-172.
Three MGHers were honored Feb. 24 with this year's Bowditch Prize, named for the self-taught 19th century celestial navigator Nathaniel Bowditch, who helped raise funds for the construction of the MGH in the early 1800s.
Thirty-six former MGH patients, ranging in age from 35 to 81, recently returned to the hospital for the inaugural pancreatic surgery patient symposium, "Through Patients' Eyes: Understanding Life After Pancreatic Surgery."
Quality and cost are two of the most important drivers of innovation in health care today. At the MGH, the Bowditch Prize is awarded annually to individuals or groups who are able to achieve substantial improvement in both of these areas.
Nearly 74 years after his death, Ernest Amory Codman, MD, FACS, is honored with a memorial headstone on his previously unmarked gravesite at the historic Mount Auburn Cemetery in Cambridge.
Efforts at Massachusetts General Hospital Cancer Center are underway to address the need for more effective treatment approaches for locally advanced and metastatic disease.
MGHers with a view of the helipad may be surprised on Christmas Eve if they catch a glimpse of an extremely unusual patient with an extremely unusual mode of transportation – aboard a magical sleigh pulled by eight tiny reindeer.
The MGH celebrated the creation of the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Gastrointestinal Cancer Research.
Established in 2008, the Warshaw Institute – named after Andrew L. Warshaw, MD, MGH surgeon-in-chief emeritus and founder of the Pancreatic Biology Lab – is a collaboration of scientists and clinicians whose mission is to extend and improve the lives of patients with pancreatic cancer through the development of innovative diagnostic and treatment options.
In General awards and recognitions: May 4, 2012
Every December for as long as many staff members can remember, a cheerful old man with a long white beard has been admitted to the MGH Department of Surgery.
Andrew L. Warshaw, MD, who stepped down as chief of Surgery earlier this year, continues to be acknowledged for his contributions to the field, particularly pancreatic surgery.
The MGH Department of Surgery hosted Lord Ara Darzi of Denham, England, as the keynote speaker of the third annual Charles D. McCabe Lecture in Surgical Education Sept. 16.
The MGH recently hosted the 21st annual meeting of The Society of Black Academic Surgeons.
MGH Hotline 6.13.11 On April 26, Andrew L. Warshaw, MD, stepped into the operating room to perform his last procedure after four decades of practice and nearly 14 years as surgeon-in-chief and chair of the MGH Department of Surgery.
MGH Hotline 1.28.11 Keith D. Lillemoe, MD, a world-renowned general surgeon who specializes in pancreatic and biliary surgery, has been selected as the MGH's next surgeon-in-chief and chief of the Department of Surgery.
MGH Hotline 12.24.10 In General awards and honors
The Andrew L. Warshaw, MD Institute for Pancreatic Cancer Research recently announced $248,750 in research awards to deepen the understanding of pancreatic cancer biology.
Andrew L. Warshaw, MD, Massachusetts General Hospital surgeon-in-chief, joins lawmakers in Washington D.C. to discuss the shortage of surgeons in the United States.
MGH Hotline 4.24.09 Nathaniel Bowditch, a self-taught, 19th century celestial navigator, helped raise support for the construction of MGH in the 1800's.
MGH Hotline: 12/05/08
Andrew L. Warshaw, MD, honored by American Pancreatis Association
Pancreatic cancer patients at the Massachusetts General Hospital Cancer Center benefit from the innovative work of The Andrew L. Warshaw Institute for Pancreatic Cancer Research which includes a community of scientists, oncologists, surgeons, radiation oncologists and interventional endoscopists whose mission is to extend and improve the lives of patients with pancreatic cancer.
Back to Top